Professional Documents
Culture Documents
Friday, January 9, 15
Index
Up/Down
Last
DJ Industrials
-169.28
0.95%
17,738
S&P 500
-17.22
0.83%
2,044
Nasdaq
-32.12
0.68%
4,704
Russell 2000
-10.32
0.88%
1,185
Economic Data
Nonfarm Payrolls for Dec rose 252K, above estimates for 240K gain, while the prior month was
upwardly revised to 353K from 321K. The unemployment rate dropped to 5.6% from 5.8% the
prior month, though wages decline (-0.2%) vs. an expected 0.2% gain. Also alarming, the
participation rate dropped to 62.7% from 62.9% prior. Nonfarm private payrolls rose 240k vs
prior 345K (est. 228K), while manufacturing payrolls edged higher
Wholesale Inventories for Nov jumped 0.8%, above est. 0.3%; wholesale inventories increased to
$547.2B vs. $542.9B in prior month; wholesale sales fell 0.3% in Nov. after no change prior
Commodities
It was another dreadful week for oil prices, falling again Friday by 43c to $48.36 per barrel, and
ending the week with an 8% decline (its 7th consecutive weekly decline). Oil dropped to the
lowest level in more than five years on same concerns, as OPEC refuses to reduce its output, and
the industry faces an oversupply surplus. Brent slid as much as 4% before paring losses (WTI fell
more than 3% before partially recovering). Oil remains near lowest levels since April 2009
Gold prices ended higher, rising $7.60, or 0.6% to settle at $1,216.60 an ounce, and advanced
2.5% for the week. A mixed jobs report helped propel precious metals higher after the December
employment report showed a gain of 252,000 jobs (more than expected), but a surprise drop in
hourly wages kept a lid on the expectations for a rise in interest rates. Silver prices inched higher
by 3c to $16.42 an ounce
Currencies
The U.S. dollar initially jumped on the better December jobs report/drop in unemployment (DXY
jumped to 92.497 high)but sold off the remainder of the day, touching a low of 92.497. The jobs
report showed job growth (positive for US economy/dollar), but also showed lack of wage growth
(not good), which weighed on the market and the dollar (which came in with a 7-day winning
streak). The dollar extended losses against the yen, while the euro advances off 9-year lows
Bond Market
Bond markets advance following the better jobs data; the 10-yr yield has been having a real
tough time trading above the 2% market (holding for 3 days now), while longer dated maturities
are falling (lifting those yields). Combination of record low bond yields in Europe, uncertainty if
Fed will raise rates in 2015 at all, keeping U.S. Treasuries strong. The yield on the 10-yr ends
below 10% this week, as low wages weigh on investor sentiment
Macro
Up/Down
Last
WTI Crude
-0.43
48.36
Brent
-0.92
50.04
Gold
7.60
1,216.10
EUR/USD
0.0045
1.18.38
JPY/USD
-1.09
118.57
10-Year Note
-0.045
1.971%
Energy
Energy complex was mostly lower, led by usual suspects (E&P, services, drillers)
Refiners; sector downgraded to market weight vs overweight at Wolfe Research on heavily oversupplied U.S. product market in spite of bubbly U.S. oil demand (downgraded PSX, HFC)
Oil drillers again leading lower in energy (RIG, DO, SDRL, ATW); RBC upgraded NE to outperform,
while cutting RDC noting outperformed group by ~25% over past year; service stocks weak, Baker
Hughes noted weekly rig count plunged to 1750 in latest week from 1811 prior
Utility sector; RBC Capital upgraded shares of CPN, EXC, EIX to Outperform, while downgrading
shares of CMS, XEL, PNW & UTL (utility stocks were weaker today, but remain near all-tie highs)
MLP sector; GMLP priced 7.2M secondary units at $29.90 per share (stocks remained under
pressure after deal); at Jefferies, NFG was cut to hold, but upgraded PAGP & PAA to buy from
hold; overall, the Alerian MLP Index (AMZ) was lower given the oil prices weakness yet again
Oil & Gas companies mostly lower with lower prices (APA, APC, CHK, DVN); HK said its 2015
Drilling & Completions budget $375M-$425M compared to $950M YoY; SD restated 2013-2014
results to incorporate new accounting treatment/reduced cap-ex/rig count
Financials
Financials underperformed the market, with banks leading (lower bond yields not helping), but
things change next week with several large cap and regional banks reporting; financials carrying
the brunt of releases as JPM & WFC report earnings on Wed; BLK, BAC, C, and CBSH on Thursday;
PNC, STI, CMA, and GS Friday
New today fairly light in space, MTG said Dec primary new insurance written $3.3B (note
mortgage insurers (MBI, ESNT, MBI, NMIH, RDN) been a hot topic this week very volatile
after the FHA announced a 50 bps premium cut to 0.85%
Regional banks, especially those in Texas which provide more loans to the energy sector than
other states, have remained under pressure given oil decline (BOKF, CF, ZION, PB, CMA to name
a few); a lower rate environment also hurts banks making money on lending (Canadian banks
also under pressure given the same loan fears)
REITs continue to be favorite of investors amid the low rate environment; Bank America raised
targets in 2 REIT sectors today: Triple-net REITs tgt EPR, NNN, O, SRC & WPC on lower assumed
risk free rate and Healthcare REITs tgts for DOC, HCN, HCP, NHI, SBRA, SNH & VTR
Insurance sector; XL agreed to purchase Catlin Group Ltd., a Lloyds of London company, for 2.8
billion pounds ($4.2B) http://goo.gl/kVlEsv ; ACE downgraded at Wells Fargo but upgraded VOYA
Healthcare
Large cap pharma; LLY downgraded at Bank America saying valuation already reflects positive
expectations; ABBV cut at Bank America (recall late yesterday, ANTM chose GILDs Hep C
treatment as primary option over ABBV Viekira Pak); CNAT plunges (cut at Piper) in response to
apparent uncertainty in its Phase 2 results evaluating its oral pan-caspase protease inhibitor,
Emricasan;
Biotechs; AMAG dropped after the FDA said it wants boxed warning on Feraheme risks; REGN
and SNY said Alirocumab monthly dose meets trial goal (Janney also initiated coverage with buy
and $519 tgt); ARGS falls as Phase 2b study of AGS-004 in HIV didnt meet primary endpoint
Small cap movers; AGEN rises after INCY enters into a global license, development and
commercialization agreement focused on novel immunotherapeutics; ANGO boosted forecasts
Want a free trial to The Hammerstone Report 4x Daily ? Sign-up for a trial today at
www.thehammerstonereport.com
***DISCLAIMER/LIMITATION OF LIABILITY: Hammerstone Inc. (the Report) provides information and data and does NOT provide any individual investment advice or money management
assistance and does NOT attempt to influence the sale or purchase of securities. The Report is intended for informational purposes only and does not claim to be actionable for investment
decisions. The information contained in the Report has been obtained from sources deemed to be reliable but is not represented to be complete, and it should not be relied upon as such. The
Report does not purport to be a complete analysis of any security, issuer, or industry and is not an offer or a solicitation of an offer to buy or sell any securities. The Report is prepared for
general information purposes only and does not consider the specific investment objectives, financial situation, and particular needs of any individual subscriber, person, or entity